DMAS Would Monitor Consumer-Directed Care

Summary#

HB 1495 directs Virginia’s Department of Medical Assistance Services (DMAS) to enhance oversight of Medicaid services facilitation for consumer-directed services. It does not amend a named Act in the supplied text; it sets out new directions for DMAS. Its stated goal is to ensure proper management of consumer-directed care. The supplied status says the bill passed the House of Delegates; it does not establish that the bill is law.

  • DMAS must include services facilitation in the statewide Fiscal Employer Agent contract.
  • DMAS must develop a contract monitoring and oversight plan.
  • The plan must monitor timely service authorization requests, annual plans of care and individualized service planning, and reassessment visits.
  • DMAS must submit state plan amendments, apply for waivers, and update provider manuals or guidance as needed to carry out the bill. The bill does not guarantee federal approval.

What it means for you#

  • Medicaid members using consumer-directed services: The plan must monitor the listed authorization and planning activities. The bill does not change eligibility or benefit amounts, or require members to apply for a review or reassessment.
  • Services facilitators and the Fiscal Employer Agent: Services facilitation must be included in the statewide contract, with a monitoring plan. The bill does not specify new individual duties or penalties for providers.
  • DMAS: The department must take the oversight and implementation steps described in the bill. The available material does not include the current law or contract, so it is not possible to verify which of these duties are already in place.

Money#

No cost estimate is provided in the supplied material.

  • The bill assigns work to DMAS but gives no budget or staffing amount.
  • It does not set a tax, fee, fine, or benefit payment.

What is unclear#

  • The bill does not define “services facilitation” or explain what “enhance oversight” requires beyond the listed monitoring.
  • It does not set monitoring standards, deadlines, reporting requirements, or consequences for problems found.
  • It is unclear whether federal approval will be needed for each implementation step, and when any changes would take effect.
  • The supplied material does not include current law or the existing contract, so the extent of change from current practice is unclear.

Case for#

  • The bill identifies specific parts of consumer-directed care for DMAS to monitor, including timely authorizations, care planning, and reassessment visits.
  • Including services facilitation in the statewide contract could give DMAS a defined contract through which to organize oversight.
  • Requiring DMAS to update state plan materials, waivers, or guidance as needed could help align implementation with federal Medicaid requirements.

Case against#

  • The bill requires enhanced oversight but leaves key details—such as standards, deadlines, reporting, and follow-up—open.
  • It assigns DMAS new work without stating how much staff or funding it will need.
  • Without the current law and contract, it is unclear how much the bill changes existing oversight or whether it overlaps with current requirements.